|
1
|
Romaszko AM and Doboszyńska A: Multiple
primary lung cancer: A literature review. Adv Clin Exp Med.
27:725–730. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheema PK, Rothenstein J, Melosky B, Brade
A and Hirsh V: Perspectives on treatment advances for stage III
locally advanced unresectable non-small-cell lung cancer. Curr
Oncol. 26:37–42. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Driesen P, Lambrechts M, Kraaij K,
Soldatenkova V, Chouaki N and Colinet B: A phase II single-arm
study of induction chemotherapy with cisplatin and gemcitabine
followed by concurrent cisplatin and gemcitabine with thoracic
radiation for unresectable locally advanced non-small cell lung
cancer. Ther Adv Med Oncol. 5:159–168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baldini E, Tibaldi C and Delli Paoli C:
Chemo-radiotherapy integration in unresectable locally advanced
non-small-cell lung cancer: A review. Clin Transl Oncol.
22:1681–1686. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hauner K, Maisch P and Retz M: Side
effects of chemotherapy. Urologe A. 56:472–479. 2017.(In German).
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pastorino G, Cornara L, Soares S,
Rodrigues F and Oliveira MBPP: Liquorice (Glycyrrhiza
glabra): A phytochemical and pharmacological review. Phytother
Res. 32:2323–2339. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei WT, Lin SZ, Liu DL and Wang ZH: The
distinct mechanisms of the antitumor activity of emodin in
different types of cancer (Review). Oncol Rep. 30:2555–2562. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Shan C, Wu Z, Yu H, Yang A and Tan
B: Emodin alleviated pulmonary inflammation in rats with
LPS-induced acute lung injury through inhibiting the
mTOR/HIF-1α/VEGF signaling pathway. Inflamm Res. 69:365–373. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu C, Zhang J, Liu J, Li Z, Liu Z, Luo Y,
Xu Q, Wang M, Zhang G, Wang F, et al: Proteomic analysis reveals
the protective effects of emodin on severe acute pancreatitis
induced lung injury by inhibiting neutrophil proteases activity. J
Proteomics. 220:1037602020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma W, Liu C, Li J, Hao M, Ji Y and Zeng X:
The effects of aloe emodin-mediated antimicrobial photodynamic
therapy on drug-sensitive and resistant Candida albicans. Photochem
Photobiol Sci. 19:485–494. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen Q, Li KT, Tian S, Yu TH, Yu LH, Lin
HD and Bai DQ: Photodynamic therapy mediated by aloe-emodin
inhibited angiogenesis and cell metastasis through activating MAPK
signaling pathway on HUVECs. Technol Cancer Res Treat.
17:15330338187855122018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zu C, Qin G, Yang C, Liu N, He A, Zhang M
and Zheng X: Low dose Emodin induces tumor senescence for boosting
breast cancer chemotherapy via silencing NRARP. Biochem Biophys Res
Commun. 505:973–978. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu M, Tang W, Liu JJ, Gong XQ, Kong L, Yao
XM, Jing M, Cai FY, Li XT and Ju RJ: Combination of targeted
daunorubicin liposomes and targeted emodin liposomes for treatment
of invasive breast cancer. J Drug Target. 28:245–258. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Akev N, Candoken E and Erdem Kuruca S:
Comparative study on the anticancer drug potential of a lectin
purified from aloe vera and aloe-emodin. Asian Pac J Cancer Prev.
21:99–106. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W, Sun Y, Li X, Li H, Chen Y, Tian Y,
Yi J and Wang J: Emodin potentiates the anticancer effect of
cisplatin on gallbladder cancer cells through the generation of
reactive oxygen species and the inhibition of survivin expression.
Oncol Rep. 26:1143–1148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Gan D, Huang Q, Luo X, Lin D and
Hu J: Emodin and Its combination with cytarabine induce apoptosis
in resistant acute myeloid leukemia cells in vitro and in vivo.
Cell Physiol Biochem. 48:2061–2073. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen S, Zhang Z and Zhang J: Emodin
enhances antitumor effect of paclitaxel on human non-small-cell
lung cancer cells in vitro and in vivo. Drug Des Devel Ther.
13:1145–1153. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Holford J, Beale PJ, Boxall FE, Sharp SY
and Kelland LR: Mechanisms of drug resistance to the platinum
complex ZD0473 in ovarian cancer cell lines. Eur J Cancer.
36:1984–1990. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi B, Xu FF, Xiang CP, Jia R, Yan CH, Ma
SQ, Wang N, Wang AJ and Fan P: Effect of sodium butyrate on ABC
transporters in lung cancer A549 and colorectal cancer HCT116
cells. Oncol Lett. 20:1482020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tian J, Hu J, Liu G, Yin H, Chen M, Miao
P, Bai P and Yin J: Altered Gene expression of ABC transporters,
nuclear receptors and oxidative stress signaling in zebrafish
embryos exposed to CdTe quantum dots. Environ Pollut. 244:588–599.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sauerborn Klobucar R, Zaja R, Franjević D,
Brozović A and Smital T: Presence of ecotoxicologically relevant
Pgp and MRP transcripts and proteins in Cyprinid fish. Arh Hig Rada
Toksikol. 61:175–182. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou J, Li Z, Li J, Gao B and Song W:
Chemotherapy resistance molecular mechanism in small cell lung
cancer. Curr Mol Med. 19:157–163. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang Y, Lei L and Liu Y: Propofol
improves sensitivity of lung cancer cells to cisplatin and its
mechanism. Med Sci Monit. 26:e9197862020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deng X, Hu Y, Ding Q, Han R, Guo Q, Qin J,
Li J, Xiao R, Tian S, Hu W, et al: PEG10 plays a crucial role in
human lung cancer proliferation, progression, prognosis and
metastasis. Oncol Rep. 32:2159–2167. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deng X, Tu Z, Xiong M, Tembo K, Zhou L,
Liu P, Pan S, Xiong J, Yang X, Leng J, et al: Wnt5a and CCL25
promote adult T-cell acute lymphoblastic leukemia cell migration,
invasion and metastasis. Oncotarget. 8:39033–39047. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong X, Luo Z, Wang Y, Meng L, Duan Q, Qiu
L, Peng F and Shen L: Altered O-glycosylation is associated with
inherent radioresistance and malignancy of human laryngeal
carcinoma. Exp Cell Res. 362:302–310. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiao L, Tsutsui T and Miwa N: The
lipophilic vitamin C derivative, 6-o-palmitoylascorbate, protects
human lymphocytes, preferentially over ascorbate, against
X-ray-induced DNA damage, lipid peroxidation, and protein
carbonylation. Mol Cell Biochem. 394:247–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong W, Liao ZG, Zhao GW, Guan XJ, Zhang
J, Liang XL and Yang M: Reversal effect of oxypeucedanin on
P-glycoprotein-mediated drug transport. Molecules. 23:18412018.
View Article : Google Scholar
|
|
29
|
Hurtado M, Sankpal UT, Chhabra J, Brown
DT, Maram R, Patel R, Gurung RK, Simecka J, Holder AA and Basha R:
Copper-tolfenamic acid: Evaluation of stability and anti-cancer
activity. Invest New Drugs. 37:27–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Y, Adebali O, Wu G, Selby CP, Chiou
YY, Rashid N, Hu J, Hogenesch JB and Sancar A: Cisplatin-DNA adduct
repair of transcribed genes is controlled by two circadian programs
in mouse tissues. Proc Natl Acad Sci USA. 115:E4777–E4785. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shah N, Liu Z, Tallman RM, Mohammad A,
Sprowls SA, Saralkar PA, Vickers SD, Pinti MV, Gao W and Lockman
PR: Drug resistance occurred in a newly characterized preclinical
model of lung cancer brain metastasis. BMC Cancer. 20:2922020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li X, Wang H, Wang J, Chen Y, Yin X, Shi
G, Li H, Hu Z and Liang X: Emodin enhances cisplatin-induced
cytotoxicity in human bladder cancer cells through ROS elevation
and MRP1 downregulation. BMC Cancer. 16:5782016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu A, Chen H, Tong H, Ye S, Qiu M, Wang
Z, Tan W, Liu J and Lin S: Emodin potentiates the antitumor effects
of gemcitabine in pancreatic cancer cells via inhibition of nuclear
factor-κB. Mol Med Rep. 4:221–227. 2011.PubMed/NCBI
|
|
34
|
Lin SZ, Wei WT, Chen H, Chen KJ, Tong HF,
Wang ZH, Ni ZL, Liu HB, Guo HC and Liu DL: Antitumor activity of
emodin against pancreatic cancer depends on its dual role:
Promotion of apoptosis and suppression of angiogenesis. PLoS One.
7:e421462012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang W, Sun YP, Huang XZ, He M, Chen YY,
Shi GY, Li H, Yi J and Wang J: Emodin enhances sensitivity of
gallbladder cancer cells to platinum drugs via glutathion depletion
and MRP1 downregulation. Biochem Pharmacol. 79:1134–1140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tseng HS, Wang YF, Tzeng YM, Chen DR, Liao
YF, Chiu HY and Hsieh WT: Aloe-emodin enhances tamoxifen
cytotoxicity by suppressing Ras/ERK and PI3K/mTOR in breast cancer
cells. Am J Chin Med. 45:337–350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang X, Lei T and Zhang M: Expression and
functions of formyl peptide receptor 1 in drug-resistant bladder
cancer. Technol Cancer Res Treat. 17:15330346187694132018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee CH: Reversing agents for ATP-binding
cassette drug transporters. Methods Mol Biol. 596:325–340. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Iyer VV, Priya PY and Kangeyavelu J:
Effects of increased accumulation of doxorubicin due to emodin on
efflux transporter and LRP1 expression in lung adenocarcinoma and
colorectal carcinoma cells. Mol Cell Biochem. 449:91–104. 2018.
View Article : Google Scholar : PubMed/NCBI
|
